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PABA peptide hydrotase (PPH) from human enterocytes i  comprised of two subunits, alpha and beta. PPHa is over 70% identical to meprin, a 
protease isolated from mouse and rat kidney. The enzyme shows a modular organization in that it contains an astacin protease domain, an adhesive 
domain, an EGF-like domain, and a putative C-terminal membrane spanning domain. Expression of a chimeric meprin-PPHa cDNA in COS-1 
cells led to the synthesis of immature, transport-incompetent homodimers. In addition, complex glycosylated forms were detected in the culture 
medium, suggesting that the enzyme is secreted after proteolytic removal of the membrane anchor. 
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1. INTRODUCTION 
PABA peptide hydrolase (PPH) has been identified as 
an enzyme activity in the human small intestinal mucosa 
capable of hydrolyzing N-benzoyl+-tyrosine-p-amino 
benzoic acid (PABA peptide), a substrate used in an 
exocrine pancreatic function test [l]. It was immunopu- 
rified and biochemic~ly characterized [2]. In addition 
to PABA peptide hydrolyzing activity, PPH cleaved a 
variety of biologically active peptides and was found to 
be dependent on bivalent metal ions. Biosynthetic la- 
belling studies in organ cultured intestinal explants 
showed that the formation of dimers in the endoplasmic 
reti~um was an early post-translations event [3]. 
cDNA cloning led to the discovery of sequence homol- 
ogies between PPH and meprin, a metalloendopeptidase 
from mouse kidney [4], and analysis of the DNA and 
protein sequence databanks found these two enzymes to 
be homologous to a protease from A~tacu~~uviatilis, a 
freshwater crayfish [5]. These studies led to the de&i- 
tion of a new family of metalloendopeptidases, the as- 
tacin family [6]. The astacin signature has been found 
in a variety of proteins or cDNA-deduced sequences, 
including the human bone morphogenic protein BMPl 
[7], UVS.2 from Xenupu laevis embryos [8], tolloid 
from Drosophila ~e~nogaster embryos 191, blastula 
protease 10 (BPlO) and SPAN from sea urchin embryos 
[ 10,l I] and LCE/HCE (low and high choriolytic en- 
zyme) from Oryzias Zatipes (fish embryo) [12]. These 
proteins are involved in early mo~hogeni~ processes, 
but so far proteolytic activity has been demonstrated 
only for BMPI and LCE/HCE. A characteristic struc- 
tural feature of some of these proteins is the uniform 
presence of EGF-like domains. The cDNA and deduced 
amino acid sequences of the alpha and beta subunits of 
meprin from mouse [ 13,141 and rat [15-l 7j have recently 
been published. The meprin alpha subunits from mouse 
and rat are 92% similar/87% identical, and thus are 
isomeric forms of the enzyme (EC 3.4.24.18). Meprin 
has been shown to contain an EGF-like domain located 
close to a putative membrane anchoring domain near 
the C-terminus of the protein. It was found to contain 
a putative propeptide sequence which was preceded by 
a hydrophobic sequence compatible with a signal pep- 
tide sequence. In mouse kidney, two forms, meprin-A 
and -B, have been found. There are inbred mouse 
strains deficient in meprin-A but not meprin-B [18]. 
Mouse meprin has been reported to exist as homo- and/ 
or hetero-oligomers (a,, a&, /&) [19], whereas rat me- 
prin appears to form ab heterodimers which form tetra- 
merit structures [161. 
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~bbrev~fio~: PPH, PABA peptide hydrolase; SDS-PAGE, sodium 
dodecylsulfate poly~~l~ide gel electrophoresis; EGF, epidermal 
growth factor; ER, endoplasmic reticulum; NP40, Nonidet 40, DOC, 
deoxycholate; PBS, phosphate-buffered saline. 
Here, we report the cloned cDNA sequence of the a 
subunit of PPH from human small intestine and its 
comparison to meprin from mouse and rat kidney. The 
three enzymes are closely related and may be species- 
specific isomers. In order to study the postsynthetic 
events leading to the formation of dimeric and oligo- 
merit structures, PPHa was expressed in COS-1 cells in 
a chimeric form (MPa) comprising the near full-length 
cDNA from PPHa and the 5’ cDNA portion from 
mouse meprina (including the start codon for methion- 
ine). These expression data show, that PPHa forms ho- 
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modimers and oligomers, and is retained in the ER of 
COS-1 cells in an immature membrane form. In addi- 
tion, a fully glycosylated form is secreted in soluble 
form. 
2. EXPERIMENTAL 
2.1. Materials 
The radiolabelled nucleotides ([a-35S]dATP, [y-“P]dATP and 
[a-“P]dCTP), [35S]Methionine, and the GeneScreen membrane were 
from Dupont/NEN. Restriction endonucleases, Thermus aquaticus 
DNA- polymerase, Klenow fragment and T4 polynucleotide kinase 
were purchased from Boehringer Mannheim. The M-MLV Reverse 
transcriptase was from United States Biochemical Corp. The Zeta- 
Probe membranes were obtained from Bio-Rad. Calf intestinal alka- 
line phosphatase was from Promega. The pXT1 and pSG5 vectors 
were from Stratagene Cloning System. The pGEX-3X vector and the 
protein A Sepharose beads were from Pharmacia Biosystem. Cell 
culture media, penicillin and streptomycin were obtained from 
GIBCO BRL. Fetal calf serum (FCS) was from Biological Industries. 
Phenylmethanesulphonyl fluoride (PMSF), pepstatin, aprotinin, leu- 
peptin, benzamidine, Freund’s adjuvant and molecular weight stand- 
ards were from Sigma Chemical Co. Immobilon membranes were 
from Millipore, ProBlot membranes from Applied Biosystems. All 
other chemicals were analytical grade from Merck. 
2.2. Enzyme purification 
PPH was immunopurified from Triton X-100 solubilized microvil- 
lus membrane vesicles of human small intestinal mucosa by a specific 
monoclonal antibody (HBB 31716136) as previously described [2] and 
analyzed by SDS-polyacrylamide gel electrophoresis, followed by 
Coomassie staining. 
2.3. Peptide sequencing 
Immunoprecipitated PPH was separated by SDS-PAGE, followed 
by electrophoretic transfer to nylon membranes. The subunits PPHu 
and PPI-I/i were visualized with Coomassie blue and cut out separately. 
N-terminal peptide sequences were obtained from blotted proteins in 
a gas-phase sequencer (Applied Biosystems, model 477). 
2.4. Isolation and characterization of PPH cDNA clones 
N-terminal peptide sequences of PPH subunits were used to design 
oligonucleotide probes using best ‘guess’ codons [20] (see Fig. 1B). The 
PPHa-specific probe had an expected homology of 2 82% to the 
target cDNA and was used to screen 150,000 to 300,000 plaques of 
a &tl 1 human intestine cDNA library. Plaques were transferred to 
Zeta-Probe nylon membranes in duplicate using a standard procedure 
[21]. The oligonucleotides were 5’-32P-labelled and hybridized over- 
night to the membranes 49’C. The hybridization solution contained 
6 x SSC (1 x SSC is 150 mM NaCl, 15 mM trisodium citrate), 1% 
SDS, l/6 vol. nonfat milk, and approx. 1 pmol/ml 32P-labelled probe. 
Membranes were washed twice in 6 x SSC, 1% SDS, and then in 
2 x SSC, 1% SDS for 15 min at the hybridization temperature. A single 
clone hybridized to the PPHa oligonucleotide probe. This isolate was 
termed PPHal, its 210 bp insert was subcloned into pBluescript (Strat- 
agene), and sequenced on both strands by the Sanger dideoxy termina- 
tion method using Sequenase (Version 2.0, United Biochemical Corp.) 
and the Ml3 Universal and reverse primers. This clone was used to 
screen about 600,000 recombinants of a aZAP human intestine 
cDNA library. Several positive clones were obtained and their inserts 
subcloned into pBluescript by in vivo rescue (Stratagene). These clones 
were all overlapping and extended the PPHal cDNA to both direc- 
tions, including the poly A sequence at the 3’ end. The largest clone 
(pPPHa22.4) contained a 2.8 kb insert and was sequenced on both 
strands by subcloning restriction fragments, generation of 3’ deletions 
(Exonuclease III from Stratagene, Mung Bean Nuclease from New 
England Biolabs), and the remaining gaps were filled by extension 
with gene-specific primers based on previously determined sequences. 
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2.5. Southern and Northern blot analysis 
For Southern blot analysis, 7 pg of genomic DNA from human 
adonocarcinoma cells, Caco-2, was digested with PvuII, PstI, HindIII, 
EcoRI, or BarnHI. The restriction fragments were separated by elec- 
trophoresis (1% agarose) and blotted by capillary transfer (20 x SSC, 
16 h) onto Zeta Probe nylon membrane. The membrane was hybrid- 
ized to a random-32P-labelled PPHal cDNA probe in standard hybrid- 
ization solution as above, at 6O’C. The membranes were washed as 
above. 
For Northern blot analysis, total RNA was prepared from human 
small and large intestinal mucosa (both normal and tumor-derived) 
and MDCK cells [22]. Polyadenylated mRNA (1 pg) was isolated from 
total RNA (= 75 pg) using the Dynabeads mRNA purification kit 
(Dynal), mRNA from human kidney was purchased from Clontech. 
mRNA was separated by electrophoresis n the absence of ethidium 
bromide in a 1% agarose-formaldehyde g l, followed by capillary 
transfer (0.05 M NaOH, 3 h) to Zetaprobe nylon membranes. Mem- 
branes were hybridized (50% formamide (deionized), 0.25 M 
NaH,PO, @H 7.2 with H,PO.,), 0.25 M NaCl, 7% (w/v) SDS and 1 
mM EDTA) to a random-‘*P-labelled PPHu. cDNA probe (42”C, 30 
min) and washed at room temperature (2 x SSC, 0.1% SDS and 
1 x SSC, 0.1% SDS, 15 min each). mRNA bands were visualized by 
autoradiography. To ensure the presence of intact mRNA on the blot, 
the membranes were stripped of the PPHcc probe and hybridized with 
an actin oligonucleotide probe. 
2.6. Construction of meprin-PPHa expression vector (pSGMPa) 
All DNA manipulations were performed as described in Sambrook 
et al. [23]. To construct he pSGMP& expression vector, the pSKMPcx 
was created by inserting a -200 bp EcoRI-PstI meprina DNA fragment 
containing the AUG start wdon (instead of the -50 bp EcoRI-PstI 
fragment from the PPHa subunit without a start codon) into 
pPPHcc22.4. First pPPHcc22.4 was digested with EcoRI and Hi&II, 
dephosphorylated and gel purified. The -200 bp EcoRI-PstI meprina 
cDNA fragment and the -1.2 kbp PstI-Hind111 PPHa DNA fragment 
were ligated into this vector resulting pSKMPcc. From this vector the 
-2.9 kbp BarnHI-BglII MPo fragment was inserted into the EarnHI- 
EgflI sites of the expression vector pSG5 creating pSGMPd (Fig. 6) 
2.7. Antibodies 
Antibodies against a fusion protein between Glutathione-s-trans- 
ferase and a portion of the human PPHa (amino acids 1421, counted 
from the coding sequence in pPPHa22.4) were raised in rabbits by 
standard procedures. The plasmid pPPG-Nl was constructed by in- 
serting a BarnHI-&ion1 (blunt ended) fragment of PPHa in the 
BarnHI-SmaI site of pGEX-3X and recutting the vector with HindIII- 
XhoI. The restriction sites were filled using DNA polymerase I, Kle- 
now fragment and religated. The fusion protein was expressed in E. 
coli [24] strain XLl-Blue (Stratagene) and was purified by two succe- 
sive SDS-PAGE. After staining of the proteins with Coomassie R-250 
prepared in water, the fusion protein was cut out of the gel and injected 
into the rabbits with Freund’s adjuvant [25]. PPH-specific monoclonal 
antibodies used were HBB 3/716/36 [26]. 
2.8. Transient expression of the pSGMPa in CO91 cells 
COS-1 cells were grown in EMEM supplemented with 10% (v/v) 
FCS, 100 units/ml of penicillin and lOO,ug/ml of streptomycin. 4x 10’ 
cells were seeded onto 6 cm cell culture dishes 24 h before transfection 
with DEAE-dextran. The method was as described by Berger and 
Kimmel [21]. The transfection cocktail (0.5 ,ug pSGMPa dissolved in 
950 ~1 PBS and 50 ~1 DEAE-dextran stock solution (10 mg/ml PBS) 
was added to previously washed COS-1 cells. The cells were incubated 
for 30 min at 37°C. 4 ml tissue culture medium supplemented with 100 
PM chloroquine was added and the cells were incubated again at 37” C 
for 2.5 h. After a shock with 10% (v/v) DMSO in EMEM for 2.5 min 
the cells were grown for 4&48 h in 5 ml EMEM containing 10% FCS 
before labelling. 
2.9. Metabolic labelling of COS-I cells 
The cells were washed with warm PBS and were incubated in 
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methionine-fry media suppl~ent~ with 10% (v/v) diaiymd FCS for 
1 h. The cells were continuously labelled with 50 @i [3fSJmethionine 
(1 Ci = 37 GBq) for 5 h or over night [273. 
2.10. Immunoprecipitation 
The cells were washed three times with ice-cold PBS and scraped off 
in 1 ml ice-cold PBS. After collection by low speed centrifugation they 
were lysed in 306 #I NP~~, 1% each in PBS. After removing the 
cell debris by high speed centrifugation 7 yl of 20% (w/v) SDS was 
added and the proteins were denatured by boiling for 5 min. 1 ml of 
HBT buffer (25 mM Tris-HCl, 50 mM NaCl, 1% (w/v) Triton X-100, 
pH 8.1) and 50,ul Sepharose A beads were added to preclear the probe. 
The immunoprecipitation with 20 ,~l anti-PPHcc antisera was as de- 
scribed previously [27]. 
2. I 1. E~do~~cos~~se H, ndo~~~osi~e F and tunicamycin treatment 
Treatment of immunoprecipitated PPHa proteins with endo H and 
endo F, and metabolic labelling of cells in the presence of tunicamycin 
was as described earlier [3,27,28]. 
2.12. Computer analysis of cDNA and proteins sequences 
For all computer assisted analysis of RNA, DNA and proteins, the 
GCG (Genetics Computer Group, Madison, Wisconsin) software 
package was used. 
3. RESULTS 
3.1. Enzyme purt~catj~~ and ~H~-ter~j~al amino acid 
sequence dete$~ination 
Analysis of the imrnunopurified PPH from small in- 
testinal mucosa by SDS-PAGE under reducing condi- 
tions yielded two distinct Coomassie-stained polypep- 
kDa 
205 
116 
97 
66 
45 
tide bands with apparent Mr = 90 kDa and 97 kDa, 
termed PPH& and PPH/3 (Fig. 1A) respectively. Amino 
acid sequence analysis of these two polypeptides re- 
vealed two different NH,-terminal sequences which, 
however, showed some sequence homology (Fig. 1B). 
3.2. Cl~~~~g and sequence a~~~s~ of the alga s~unit 
of PPH cDNA 
Fig. IA. Analysis of immunoprecipitated PPH by SDS-PAGE. PPH 
was immunoprecipitated from Triton X-100 solubilized microvillus 
membrane vesicles prepared from hman small intestinal mucosa 
using a specific monoclonal antibody. Electrophoresis was in a 7.5% 
DS-polyacrylamide gel under reducing conditions. Proteins were 
stained by Coomassie blue R-250. Markers are identified by A&, in the 
left lane. 
Upon screening of a Agtl 1 library from human small 
intestine, using the PPHa-specific oligonucleotide 
probe, a cDNA fragment of 210 bp was isolated. This 
cDNA fragment, which contained an open reading 
frame of 67 amino acids, including the 24 amino acids 
sequenced from the NH,-terminus of detergent-solubil- 
ized PPH&, was utilized to probe a Zap11 human intes- 
tinal cDNA library. Among several clones isolated the 
largest had an insert of 2.8 kb, contained the entire 210 
bp sequence of the probe, a stop codon and a polyA tail. 
The isolated 2.8 kb clone encoded 714 amino acids and 
included the NH2 terminal amino acid sequence of ma- 
ture PPHa (Fig. 2). Although the open reading frame 
extended from the NH, terminus, it did not contain a 
starting methionine. The NH, terminal amino acid se- 
quence of the detergent-solubilized mature & submit of 
PPH starts at position Asn34 and is indicated by a solid 
triangle in Fig. 2. A hydropathy analysis according to 
Kyte and Doolittle [29] revealed a 26 amino acid long 
hydrophobic peptide starting from His683 to Leu”*. This 
is followed by a short hydrophylic peptide (6 amino 
acids) ~on~n~g three positively charged residues 
which represent he COOH-terminus of the translated 
sequence. These two peptide segments probably repre- 
sent a membrane-spanning domain and a short cy- 
tosolic domain respectively. As previously reported [6], 
PPH& is a member of the newly defined family of met- 
ailoendo~ptidases, the astacin family. The astacin do- 
main in PPHct spans from Asn% to Hisz3’, and contains 
the extended consensus equence, HEXXHXXGFXHE- 
(Q,H)XRXDRDX(Y,H)(V,I)X(I,V), found in all pro- 
teins of the astacin family. In analogy to astacin, the 
residues involved in the zinc-binding in PPHol are Hislz3 
(His9’ in astacin), Hisn7 (His% in astacin), His’33 (H~s~~* 
in astacin), and Tyfisz (Tyr’49 in astacin). Also con- 
served within the astacin signature of PPHcl are four 
cysteine residues which have been shown to be involved 
in disuliide-bonding in astacin [5]. Thus, Cys7$ is proba- 
bly linked to Cys2” and Cys% is linked to CysiL5. 
The inte~e~ng sequence between the putative mem- 
1 5 10 15 
Fig. 1B. N-terminal amino acid sequences of the alpha and beta subunits of PPH. After SDS-PAGE, proteins were electroblotted onto ProBlot 
membranes, stained with Coomaasie blue R-250 and excised for direct sequencing in an Applied Biosystems Sequencer model 477 fitted with a 
blotting cell. The PPHu-specific oligonucleotide probe used for initial screening of cDNA libraries is as shown. 
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720 
240 
721 
241 
Sit! 
270 
811 
271 
I.801 
601 
1890 
630 
1891 AGGACCATRRCTGGCCACAGGTRCTTCRGAGACCCRTGTGGGGATGG 1980 
631 DHNWPQYFRDPSDPNPCDNDGICVNVKGMA 660 
1981 
661 
2070 
690 
2071 TGATCGGAGGCACGGCTGGCGTGATCTTCTTGACCTTCTCCATCATCGCCATCCTTTCCC~AGGCC~GG~Gtg~CCtqCctqctqgc 
691 IGCTAGVIFLTFSIIAILSPRPRK’l14 
2160 
2161 2250 
2251 2340 
2341 2430 
2431 2520 
2521 2610 
2611 2700 
2701 2790 
2791 2814 
Fig. 2. cDNA and deduced amino acid sequence of the alpha subunit of PPH. The 2.8 kb cDNA had an open reading frame to the stop codon 
of 714 amino acids. The N-terminal Asn of the mature PPHcc is indicated by a closed triangle. The sequence Asx?-His’” represent he astacin 
domain (marked 0). The extended astacin motif is double underlined. Cy~~‘-Cys~‘~ (underlined by a solid line) show the EGF-like domain; the 
bold italic sequence is the putative membrane anchor domain. Conserved cysteines in the astacin and the EGF domain known to be involved in 
disulfide bonding are in bold type. Possible ~-glycosylation sites are underlined by stars. 
TCATAGARCACGAGATCCTGCATGCTTTGGGATTTACCACATCTGGTGGGACC 450 
IEHEIZHALGFYHEQSRTDR~~Y”~~~“~~ 150 
brane spanning domain and the astacin domain har- 
bours other known motifs. One of these is an EGF-like 
domain spanning from CysM2 to Cys6” (36 amino 
acids), that contains six conserved cysteine residues. 
Another domain of about 170 amino acids mediately 
following the astacin domain has recently been de- 
scribed as an adhesive domain [30]. In addition, PPHa 
contains six potential N-glycosylation sites, two within 
the protease domain, and four within the intervening 
sequence. The domain structure of PPH@ is depicted in 
Fig. 3. 
3.4. Southern blot analysis 
For Southern blot analysis, genomic DNA was iso- 
lated from the human colon carcinoma cell line Caco-2 
and probed with PPHal after digestion with restriction 
nucleases. The results are shown in Fig. 4 and revealed 
only one or two bands per restriction digest, indicating 
that the gene encoding PPHa is a single copy gene. 
3.5. Expression of PPHa in human tissue 
The expression of PPHa mRNA in different human 
tissues was investigated using Northern blot analysis. 
Screening of mRNA from human heart, brain, placenta, 
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signal peptide - 
pro-peptide - 
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NH2 
Fig. 3. Domain structure of the alpha subunit of PPH. The schematic 
representation of the proposed domain structure of PPHo is drawn to 
scale and the ditTerent domains indicated by arrows. 0, potential 
N-glycosylations ites; -, cysteine residues. 
lung, liver, skeletal muscle, kidney and pancreas with a 
PPHcl cDNA probe gave a negative result for all these 
tissues, whereas positive signals were obtained with an 
actin probe (data not shown). Northern blot analysis 
using mRNA prepared from human small intestinal 
mucosa, large intestinal mucosa, large intestinal tumor 
tissue, human kidney and MDCK cells is shown in Fig. 
5. The strongest signal using a PPHa-specific probe 
(PPHa22.4) was obtained with mRNA from small intes- 
tinal mucosa. Weaker signals were obtained with 
mRNA from large intestinal mucosa and also large in- 
Fig. 4. Southern blot analysis. For this analysis, genomic DNA pre- 
pared from the human adenocarcinoma cell line Caco-2 was used. 7 
,ug DNA were digested with restriction enzymes indicated on the top 
of each lane and probed with PPHal cDNA. DNA sizemarkers are 
Fig. 5. Northern blot analysis. mRNA (= 1 &lane) from human small 
intestine (lane l), human colon (lane 2), human colon tumor (lane 3) 
MDCK cells (negative control, lane 4), and human kidney (lane 5) was 
electrophoresed and blotted onto nylon membrane. Hybridization was 
with a random labelled “2P-PPHa cDNA probe as described in meth- 
indicated on the left. ods. RNA sizemarkers are indicated on the left. 
testinal tumor tissue. No signal was obtained with 
mRNA from human kidney or MDCK cells. This sug- 
gests that the expression of PPHa is very tissue-specific 
being restricted to the gastrointestinal tract in human. 
3.6. Expression of meprin-PPHa (MPa) in CO&l cells 
The expression of the PPHa subunit alone in a cell 
line was carried out to determine if homodimer forma- 
tion occured. Due to the lack of the S-end in our PPHa 
cDNA we constructed a chimeric cDNA (MPa) which 
included the Y-end from the alpha subunit of mouse 
meprin, encoding the starting methionine and a putative 
signal peptide sequence (Fig. 6). In vitro transcription/ 
translation of this cDNA construct in rabbit reticulo- 
cytes resulted in a single product with an apparent 
M, = 90 kDa (not shown). The products immunoiso- 
lated from transfected C&l cells after continuous la- 
belling with [35S]methionine for 5 h are shown in Fig. 
7A and B. Analysis of the expressed protein by SDS- 
PAGE under reducing conditions revealed two bands of 
A& x 100 kDa and 90 kDa (Fig 7A, lane 1). Treatment 
of the immunoprecipitated MPa with endoglycosidase 
H (Fig. 7A, lane 2) and endoglycosidase F (Fig. 7A, lane 
3) respectively, showed a shift of the upper band to the 
lower band (90 kDa). Metabolic labelling of transfected 
COS-1 cells in the presence of tunicamycin, an inhibitor 
of N-linked glycosylation, only resulted in the 90 kDa 
species being synthesized (Fig. 7A, lanes 4 and 5). These 
results indicate, that the two synthesized MPa proteins 
detected after 5 h of labelling correspond to a non- 
glycosylated form (M, = 90 kDa) and an immature 
high-mannose form (M, = 100 kDa). Fig. 7B shows the 
SDS-PAGE analysis of the expressed MPa under reduc- 
ing conditions (lane 1) and under non-reducing condi- 
tions (lane 2). It shows that a large amount of MPa, 
when analyzed under non-reducing conditions was in an 
apparent dimeric form. A considerable amount of pro- 
teins, however, did not enter the gel properly, indicating 
the presence of oligomers or aggregates. MPa could 
also be immunoprecipitated in an endo H resistent form 
from the culture medium of transfected COS-1 cells 
(data not shown). 
kb 
5.3 
2.6 
1.6 
1234 5 
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Fig. 6. Construction of a meprin-PPHu expression vector @SGMPct). To construct this full-length chimera, a 50 bp EieRI-PstI fragment from 
pPPHc122.4 was replaced by a 200 bp EcoRI-PstI fragment from the alpha subunit of mouse meprin cDNA (pMep723) (for details see experimental 
procedures). The chimer& cDNA (pSKMPa} was subcloned into the pSG.5 vector, thus creating the pSGMPa expression vector. 
4. DISCUSSION 
The cDNA deduced amino acid sequence of the ma- 
ture alpha subunit of PPH (amino acid 34-714 in Fig. 
2) comprises 681 amino acids and has a calculated mo- 
lecular weight of 80,565. As previously reported [6] it 
contains the astacin protease domain with an identity 
score of 31% to actacin and 82% to meprina. Compar- 
ison to the recently published X-ray crystal structure of 
astacin [31,32] suggests that all the residues involved in 
the proposed pentavalent ~nc-binding site are con- 
served in PPHa. This ZinG~oor~nation site, involving 
12 3 4 5 
CH F TT 
Geltop _ 
205 kDa _ 8 
1 2 
Fig. 7. Transient expression of PPHa (MPu chimera) in COS-1 cells. 
The pSGMPa vector was used to transfect COS-1 cells (for details see 
experimental procedures). 4&48 h after transf~tion, cells were la- 
belied for 5 h with [?J]methionine, PPHa was ~m~opr~ipitat~ 
using a specific polyclonal antibody and analyzed by SDS-PAGE 
(7.5%). (A) SDS-PAGE under reducing conditions. Lane 1, control; 
lane 2, treatment of immunoprecipitate with endo H; lane 3, treatment 
of immunoprecipitate with endo F, lanes 4 and 5, metabolic labelling 
in the presence of 5 &ml and 10 &ml of tunicamycin respectively. 
(B) SDS-PAGE under reducing conditions (mne I) and under non- 
reducing conditions (lane 2). 
Tyr”‘, (equivalent o Tyr149 in astacin) is different from 
other zinc-proteases uch as thermolysin and carboxy- 
peptidase A [33,34]. Based on the zinc-binding site, 
Jiang and Bond [35] have recently proposed a scheme 
for the classification of met~loproteases into five dis- 
tinct families, namely thermolysin, astacin, serratia, ma- 
trixin and snake venom metalloproteinases. Also con- 
served in PPHa are four cysteine residues which have 
been shown to be involved in disulfide-bonding in as- 
tacin [S]. On the basis of the available X-ray crystal and 
sequence data, Stocker et al. [32] have compared astacin 
with the alpha subunit protease domain of mouse me- 
prin and have shown a close structural relationship of 
these two proteases. 
The deduced amino acid sequence of PPHa reported 
here shows 85% similarity/75% identity to the alpha 
subunit of mouse meprin [13] and 86% si~larity/78% 
identity to the alpha subunit of rat meprin [ 15] (Fig. 8). 
Compared to the primary sequences of the c1 subunits 
of meprin from mouse and rat, our protein is short of 
an estimated 44 [13] and 32 amino acids [15] respec- 
tively. Both rat and mouse meprin alpha subunits have 
a methionine in position 14 (Fig. 8). The additional 
methionine in the mouse enzyme (position 1, Fig. 8), 
suggests that the two alpha subunits are different in the 
two rodent species. As discussed by Jiang et al. [13] the 
missing NH,-terminal peptide in PPHa probably repre- 
sents a cleavable signal sequence. Amino acid sequence 
dete~ination of MPa expressed in MDCK cells have 
clearly established this experimentally [36]. The 33 
amino acids in front of the NH,-terminal Asn in our 
sequence therefore constitute part of a potential propep- 
tide sequence. The peptide bond Arg33-Asn34 iscompat- 
ible with a cleavage site for a trypsin-like protease. It 
has been shown that mouse meprin may be activated by 
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FSFNEEESIP TITTXIPEFN 
FSFPXNETIP TITTXIPEFN 
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DECTFEKANI CCMIOCTRDD 
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NTCNVRQLAK IQTFQCDSDE 
ntCnVRqLaI[ IQTFQCDsDB 400 
CCIYLDDITL TETPCPTCVW 
CGIYLDDITL TETPCPAGVW 
CCIYLDDITL TkTPCPTCVW 
CCIYLDDITL TETPCPtCVW 450 
FGVTLYPNSR ,ES.SCYLRL 
VCVTLYPNGR ITSNSCLLCL 
FCVTLYPNGR ITSNSCYLCL 
fCVTLYPNgR itSnSCyLgL 500 
PDVRNRMSSS HVFTTSASUT 
ADTRNRHSLZ LXFTTSKNQT 
PDARNRMSLS LXFTTSKYQT 
pD.RNRXSls lmFTTSX.qT 550 
LCWSCFISEQ XLXRRSFLXN 
WCWCQAISRQ LLXRRNFLXC 
WCWCQAISBQ WLMRRNFLKD 
wCWgq*ISIiQ q LkRRnFLK. 600 
CLILQEQPQQ VSEEGSCKAU 
CLLLQCQESP ALCESSRXAX 
CLLLQCQEFL ALGD.SRIAX 
CLlLQCQP . . algt.SrkAN 650 
NWPQYFRDPC DPNPCQNDCI 
NWFQYFRDPC DPUPCQNLC2 
NWPQYFRDPC DPNPCQNECT 
NWPQYFRDPC DPUPCQNsCt 700 
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Fig. 8. Comparison f the cDNA deduced amino acid sequences from PPHa, and meprina of mouse and rat. Complete primary sequence of the 
three enzymes, including a consensus equence is shown. Abbreviations: PPH, PABA peptide hydrolase; Mep, meprin; and -H, human; R, rat; M, 
mouse. 
the treatment with trypsin in vitro [18]. PPHa when 
expressed in COS- 1 or MDCK cells is not enzymatically 
active but upon treatment with trypsin can be activated 
by conversion to the mature form [36]. It has been pro- 
posed that the NHrterminal alanine in astacin forms a 
salt-bridge with G1u’03 [32,37]. In analogy, the Asn 
found at the N~~-te~~us of mature PPHa could form 
such a salt-bridge with G~u’~. The removal of the 
Another feature present in PPH and meprin is an EGF- 
like domain, comprising 36 amino acids (residues Cy@” 
to Cys677 in PPHa) and containing six conserved cyste- 
ine residues. As reviewed by Appella et al. [38], these 
cysteines are involved in the formation of disulfide 
bonds, resulting in a common structural folding shared 
by the EGF-like domains. EGF is involved in prolifera- 
tive and developmental effects which are mediated by 
propeptide therefore constitutes an essential step in the 
activation process of these enzymes. 
a specific surface receptor endowed with protein tyro- 
sine kinase activity [39,40]. Single or multiple copies of 
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FEVITSGHQ---GYLAIDEVXVLGH----PCTR 
FEWTSGHQ---GYLAIDEVXVLGH----PCTR 
VEGTVGX--GSAGGIAMDIIIANHISPSQCR.A 
*. .*.. * 
50 
100 
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Fig. 9. Alignment of the adhesive (MAM) domains. The sequences were aligned using CLUSTAL V. The strictly conserved residues are indicated 
by asterisks and the similar residues by dots. Abbreviations: RPTP, receptor protein tyrosine phosphatase; PPH, PABA peptide hydrolase; Mep, 
meprin; and -H, human; R, rat; M, mouse; X, Xenopus. 
EGF-like domains have been found in many diflerent 
proteins, including most astacin family members 
[13,32]. Many proteins with EGF-like domains are 
growth factors, cell surface receptors or receptor-like 
proteins. Proteases containing an EGF-like sequence 
characterized to date have been shown to be involved 
in the proteloytic activation of zymogen or precursor 
molecules. Regulatory functions have also been sug- 
gested for some astacin proteases. The tight association 
of BMP-1 with BMP-2 and BMP-3, both peptide 
growth factors of the TGF-/I family, strongly suggests 
that it directly or indirectly regulates the activities of 
these factors 171. This idea is strengthens by the rela- 
tion of BMP-2 to the decapentaplegic gene (dpp), which 
plays a crucial part in pattern formation in Drosophila 
and which in turn has been suggested to be regulated by 
tolloid, another member of the astacin family of pro- 
teases [9]. 
Recently, Beckmann and Bork have described an- 
other domain, which is present in diverse plasma-mem- 
brane-bound proteins such as protein tyrosine phos- 
phatase ,u, A5 protein, and the alpha and the beta sub- 
units of meprin [30]. This MAM domain (,u, A5, me- 
prin) comprises about 170 amino acids and can also be 
found in PPHa (Fig. 9). The exact function of MAM is 
not clear, but it has been suggested that it is likely to 
have a common adhesive function in these proteins, and 
it is quite likely that the conserved cysteine residues play 
an important role. Four cysteines are conserved in all 
of the proteins in Fig. 9 and one more cysteine is con- 
served in all meprin/PPH proteases. This additional Cys 
374 
residue in rnep~~P~ might be important for inter- 
subunit interaction. 
Tissue expression of PPHcc in human appears to be 
limited to the gastrointestinal tract. A notable finding 
was the apparent lack of enzyme in human kidney. The 
alpha subunit of mouse meprin has been found in the 
kidney of random bred mice but not in mice which are 
deficient in meprin A [41]. The meprinol subunit was not 
detected in the mouse intestine, while in the rat, it was 
expressed in kidney and intestine. In rat kidney, the 
alpha subunit has been shown by in situ hybridization 
to be expressed only in specific cells of the juxtamedul- 
lary region [ 151 providing further evidence for the highly 
specific expression of this enzyme. Taken together, 
these data indicate, that meprir&PPHa expression is 
tissue-specific and differs from one species to another. 
Expression of the MPcl chimer& protein in COS-1 
cells has led to the isolation of an immature enzyme as 
demonstrated by the persisting sensitivity to endoglyco- 
sidase H, suggesting that the protein is not able to exit 
from the ER compartment in COS-1 cells. The expres- 
sion data clearly show that homodimers of MPcl are 
formed in the ER, which is in agreement with organ 
culture data using human small intestinal mucosa [3]. A 
soluble and partially endo H resistant form was immu- 
noisolated from the medium of transfected COS-I cells. 
These data indicate that MPcl expressed in COS-1 cells 
is synthesized as transport-incompetent membrane- 
bound form which cannot be exported from the ER 
compartment. The observation of a fully glycosylated 
soluble form of MPa. in the culture medium, suggests 
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that proteolytic events lead to the secretion of a trun- 
cated form of MPa. 
This work establishes the relationship of the 01 sub- 
units of PPH as an isoenzyme of meprin (EC 3.4.24.18). 
As a member of the astacin family of proteases, in addi- 
tion to a zinc-protease domain, PPHa contains other 
functional domains such as the EGF-like motif and the 
adhesion domain (MAM). The function of PPH in 
human small intestine is not known, but the complex 
modular organization distinguishes this enzyme from 
other proteases involved in simple digestive processes. 
Considering the continuous process of cell prolifera- 
tion, migration and differentiation that occurs in the 
intestinal mucosa, it is conceivable that PPH is involved 
in the processing of precursor proteins or the regulation 
of growth factors. It might also be speculated, that PPH 
itself, due to its EGF-like domain, can function as a 
growth factor in intestinal morphogenesis. Detailed 
studies of the expression of PPH in different cells of the 
intestinal mucosa in combination with heterologous ex- 
pression of the PPHa and PPH/3 subunits are in pro- 
gress to address these questions. 
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